MLL
RTO icon

Moody Lynn & Lieberson’s Rentokil RTO Stock Holding History

Moody Lynn & Lieberson’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,746
Closed -$475K – 245
2024
Q1 		$475K Buy
15,746
+31
+0.2% +$860 0.03% 166
2023
Q4 		$450K Hold
15,715
– – 0.03% 165
2023
Q3 		$582K Buy
15,715
+115
+0.7% +$4.39K 0.05% 134
2023
Q2 		$609K Sell
15,600
-183
-1% -$7.17K 0.05% 138
2023
Q1 		$576K Buy
15,783
+147
+0.9% +$4.64K 0.05% 144
2022
Q4 		$481K Buy
+15,636
New +$485K 0.04% 158

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Moody Lynn & Lieberson's RTO Position: Q2 2024 in Review

Moody Lynn & Lieberson sold out of Rentokil (RTO) in Q2 2024, closing a stake of 15,746 shares — an estimated $475K sold.

Moody Lynn & Lieberson first reported a position in RTO in Q4 2022 and held it in 6 quarters. The position peaked at $609K in Q2 2023. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • Moody Lynn & Lieberson reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • Moody Lynn & Lieberson sold 15,746 Rentokil shares in Q2 2024, an estimated $475K.
  • Moody Lynn & Lieberson first reported a position in Rentokil in Q4 2022 and held it in 6 quarters.
  • Moody Lynn & Lieberson's Rentokil position peaked at $609K in Q2 2023.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Moody Lynn & Lieberson's 13F filing for Q2 2024, filed 25 Jul 2024.